The federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An advisory panel at the FDA last week voted on which strains of the virus to target in an updated formulation for the...
After a successful kick-off meeting in November 2022, the AIB had its first technical meeting entitled: Assessing the health burden of vaccine-preventable infections in European Adults: challenges and opportunities. The...
The Advisory Committee on Immunization Practices has updated its vaccination recommendations for immunocompetent adults aged 65 years or older to extend the interval between receipt of the Prevnar 13 and Pneumovax 23...